Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple‐negative breast cancer
WIREs Nanomedicine and Nanobiotechnology · 2024
DOI: 10.1002/wnan.1950 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2024. Verfasst von Ye Cao und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Moderniz…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Triple Negative Breast Neoplasms, Nanoparticles. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 132 Literaturangaben. Gefördert von: Key Program of International (Regional) Cooperative Research Projects of the National Natural Science Foundation of China, National Key R&D Program of China (International Programs & Strategic Innovative Programs, International Joint Research Center for Anti-tumor Nanomedicine Innovation and Application.
Abstract (Originalsprache)
The conventional therapeutic treatment of triple‐negative breast cancer (TNBC) is negatively influenced by the development of tumor cell drug resistant, and systemic toxicity of therapeutic agents due to off‐target activity. In accordance with research findings, nanoparticles (NPs) responsive to the tumor microenvironment (TME) have been discovered for providing opportunities to selectively target tumor cells via active targeting or Enhanced Permeability and Retention (EPR) effect. The combination of the TME control and therapeutic NPs offers promising solutions for improving the prognosis of the TNBC because the TME actively participates in tumor growth, metastasis, and drug resistance. The NP‐based systems leverage stimulus‐responsive mechanisms, such as low pH value, hypoxic, excessive secretion enzyme, concentration of glutathione (GSH)/reactive oxygen species (ROS), and high concentration of Adenosine triphosphate (ATP) to combat TNBC progression. Concurrently, NP‐based stimulus‐responsive introduces a novel approach for drug dosage design, administration, and modification of the pharmacokinetics of conventional chemotherapy and immunotherapy drugs. This review provides a comprehensive examination of the strengths, limitations, applications, perspectives, and future expectations of both novel and traditional stimulus‐responsive NP‐based drug delivery systems for improving outcomes in the medical practice of TNBC. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) o…
- Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Traditional Chinese Medicine, Zhongshan, China.
- College of Life Sciences, Liaoning University, Shenyang, China.
- College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
- Research Institute for Physical Chemical Problems of the Belarusian State University, Minsk, Belarus.
- Faculty of Physics, Lomonosov Moscow State University, Moscow, Russia.
ORCID-Profile: Uladzislau E Aharodnikau, Timoshenko Viktor, Yu Cai
Förderung
- Key Program of International (Regional) Cooperative Research Projects of the National Natural Science Foundation of China
- National Key R&D Program of China (International Programs & Strategic Innovative Programs
- International Joint Research Center for Anti-tumor Nanomedicine Innovation and Application
- International (Regional) cooperation and exchange program of National Natural Science Foundation of China
- Natural Science Foundation of China
- Science and Technology Projects in Guangzhou
- Fifth National Traditional Chinese Medicine Excellent Talents Training Program under Grant (2022)
- National Natural Science Foundation of China
Zitieren
APA
Cao, Y., Meng, F., Cai, T., Gao, L., Lee, J., Solomevich, S. O., Aharodnikau, U. E., Guo, T., Lan, M., Liu, F., Li, Q., Viktor, T., Li, D., & Cai, Y. (2024). Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple‐negative breast cancer. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1950
Vancouver
Cao Y, Meng F, Cai T, Gao L, Lee J, Solomevich SO, et al. Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple‐negative breast cancer. WIREs Nanomedicine and Nanobiotechnology. 2024. doi:10.1002/wnan.1950
BibTeX
@article{Cao2024,
author = {Cao, Ye and Meng, Fansu and Cai, Tiange and Gao, Lanwen and Lee, Jaiwoo and Solomevich, Sergey O and Aharodnikau, Uladzislau E and Guo, Tingting and Lan, Meng and Liu, Fengjie and Li, Qianwen and Viktor, Timoshenko and Li, Detang and Cai, Yu},
title = {Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple‐negative breast cancer},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
doi = {10.1002/wnan.1950}
}
EUVIMED